Combination Therapy of Gefitinib and Korean Herbal Medicines Could be a Beneficial Option for Patients with Non-Small-Cell Lung Cancer

ABSTRACT: ABSTRACT: Lung cancer has a high mortality rate and is often diagnosed at the metastatic stage. Gefitinib is a targeted molecular therapeutic drug used to treat patients with non-small-cell lung cancer (NSCLC). Korean herbal medicines may also have therapeutic efficacy against lung cancer,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Kangwook, Kim, Yoon-sik, Son, Chang-Gue, Cho, Jung-Hyo, Yoo, Hwa-Seung, Lee, Jonghoon, Ryu, Juyoung, Lee, Namhun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KOREAN PHARMACOPUNCTURE INSTITUTE 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043091/
https://www.ncbi.nlm.nih.gov/pubmed/27695636
http://dx.doi.org/10.3831/KPI.2016.19.028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043091/
https://www.ncbi.nlm.nih.gov/pubmed/27695636
http://dx.doi.org/10.3831/KPI.2016.19.028

Ejemplares similares